Suppr超能文献

超滤液分子量截止值对人乳蛋白浓缩物制备过程中的浓度和蛋白质图谱影响有限。

The ultrafiltration molecular weight cut-off has a limited effect on the concentration and protein profile during preparation of human milk protein concentrates.

机构信息

Departement of Food Science, Institute for Nutrition and Functional Foods (INAF) and Dairy Research Centre (STELA), Laval University, Quebec, G1V 0A6 Canada.

Department of Food Science, University of Copenhagen, Frederiksberg C, DK-1958 Denmark.

出版信息

J Dairy Sci. 2021 Apr;104(4):3820-3831. doi: 10.3168/jds.2020-18762. Epub 2021 Jan 21.

Abstract

Optimizing protein intake for very low birth weight (<1,500 g) infants is fundamental to prevent faltering postnatal growth with the potential association of impaired neurodevelopment. The protein content of human milk is not sufficient to support the growth of very low birth weight infants. To meet their elevated protein requirements, human milk is currently fortified using typically bovine milk-based protein isolates (>85% on a dry basis). However, these products have several limitations for use in this vulnerable population. To overcome the shortcomings of bovine milk-based protein supplement, a human milk protein concentrate (HMPC) was developed. In preliminary attempts using 10 kDa ultrafiltration (UF) membranes, it was not possible to reach the protein content of commercial protein isolates, presumably due to the retention of human milk oligosaccharides (HMO). Consequently, it was hypothesized that the use of a UF membrane with a higher molecular weight cut-off (50 kDa rather than 10 kDa) could improve the transmission of carbohydrates, including HMO, in the permeate, thus increasing the protein purity of the subsequent HMPC. The results showed that permeate fluxes during the concentration step were similar to either UF molecular weight cut-off, but the 50-kDa membrane had a higher permeate flux during the diafiltration sequence. However, it was not sufficient to increase the protein purity of the human milk retentate, as both membranes generated HMPC with similar protein contents of 48.8% (10 kDa) and 50% (50 kDa) on a dry basis. This result was related to the high retention of HMO, mainly during the concentration step, although the diafiltration step was efficient to decrease their content in the HMPC. As the major bioactive proteins (lactoferrin, lysozyme, bile salt stimulated lipase, and α1-antitrypsin) in human milk were detected in both HMPC, the 50-kDa membrane seems the most appropriate to the preparation of HMPC in terms of permeation flux values. However, improving the separation of HMO from proteins is essential to increase the protein purity of HMPC.

摘要

优化极低出生体重(<1500 克)婴儿的蛋白质摄入量对于防止出生后生长缓慢至关重要,因为这可能会对神经发育造成损害。母乳中的蛋白质含量不足以满足极低出生体重婴儿的生长需求。为了满足他们对蛋白质的高需求,母乳目前通过使用典型的基于牛乳的蛋白质分离物(干物质基础上>85%)进行强化。然而,这些产品在这个脆弱的人群中使用存在几个局限性。为了克服基于牛乳的蛋白质补充剂的缺点,开发了一种人乳蛋白质浓缩物(HMPC)。在使用 10 kDa 超滤(UF)膜的初步尝试中,由于人乳低聚糖(HMO)的保留,无法达到商业蛋白质分离物的蛋白质含量,这大概是由于人乳低聚糖(HMO)的保留。因此,假设使用更高分子量截止值(50 kDa 而不是 10 kDa)的 UF 膜可以改善碳水化合物(包括 HMO)在渗透物中的传输,从而提高后续 HMPC 的蛋白质纯度。结果表明,浓缩步骤中的渗透通量与 UF 分子量截止值相似,但在渗滤序列中,50 kDa 膜具有更高的渗透通量。然而,这不足以提高人乳保留物的蛋白质纯度,因为两种膜生成的 HMPC 的蛋白质含量相似,分别为 48.8%(10 kDa)和 50%(50 kDa),均以干物质为基础。这一结果与 HMO 的高保留有关,主要是在浓缩步骤中,尽管渗滤步骤可以有效地降低 HMPC 中的 HMO 含量。由于人乳中的主要生物活性蛋白(乳铁蛋白、溶菌酶、胆汁盐刺激的脂肪酶和α1-抗胰蛋白酶)均在两种 HMPC 中被检测到,因此 50 kDa 膜在渗透通量值方面似乎最适合 HMPC 的制备。然而,提高 HMO 与蛋白质的分离度对于提高 HMPC 的蛋白质纯度至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验